The long-established Italian brand OPTIKA was acquired by the South Korean company Bio-Medical Science Co., Ltd. (BMS Group) in late 2025. The BMS Group operates in the life sciences and laboratory technology sectors and brings together several established brands under one roof, including the centrifuge manufacturer GYROZEN, whose VITARIS products have been successfully distributed in Switzerland for several years. By combining the expertise of OPTIKA and GYROZEN, customers will benefit in the future from innovative solutions, shorter delivery times, and an improved supply of replacement parts.
About OPTIKA
OPTIKA was founded in Italy in 1971 and has made a name for itself worldwide as a manufacturer of high-quality microscopes, imaging systems, and laboratory equipment. Through its integration into the BMS Group, the company gains access to additional resources, expanded research and development capabilities, and a global sales network, while retaining the brand and its Italian identity.
Kangsan D. Kim, Director of BMS Group: “We are proud to welcome Optika to the BMS family. Optika’s expertise in optical technologies aligns seamlessly with our long-term vision. Together, we will drive innovation and deliver even greater value to our customers worldwide.”
Synergies with GYROZEN open up new possibilities
Of particular interest to customers is the partnership with GYROZEN, a manufacturer of laboratory centrifuges with an outstanding reputation in the life sciences industry. GYROZEN is also part of the BMS Group and enjoys an excellent reputation for quality, reliability, and innovative technology. The centrifuges are now also being marketed under the OPTIKA brand. In addition, the goal is to shift a significant portion of production to Italy in the long term.
This offers concrete benefits for GYROZEN centrifuge users in Switzerland:
- Shorter delivery times thanks to European production and logistics structures
- Faster availability of replacement parts and accessories
- Streamlined Service and Support Processes
- Improved Security of Supply
- More attractive long-term cost structures for maintenance and replacement parts
OPTIKA thus combines its European presence and commitment to service with GYROZEN's proven technology and performance.
What does this mean for VITARIS customers?
GYROZEN centrifuges are now being offered in Switzerland under the OPTIKA brand. For VITARIS, this development opens up new opportunities to offer laboratories high-quality and cost-effective solutions from a single source. In addition to OPTIKA’s established microscopy portfolio, high-performance centrifuges are now available that are based on a proven technology platform and also benefit from a stronger European presence.
This provides an attractive alternative to established manufacturers, particularly for research institutes, universities, biotech companies, pharmaceutical companies, and routine laboratories. Customers benefit from a combination of high product quality, long-term investment security, and a local point of contact.
Next Steps at VITARIS
VITARIS will continue to actively support the development of OPTIKA and GYROZEN and strategically expand its product portfolio. Our goal is to offer Swiss laboratories state-of-the-art centrifuge and microscopy solutions that combine the highest quality with an attractive price-performance ratio.
Through our close collaboration with OPTIKA, we are able to not only provide our customers with innovative products, but also offer expert local support, guidance in selecting equipment, and assistance throughout the entire lifecycle of the instruments.
Conclusion
The BMS Group’s acquisition of OPTIKA is thus much more than just a change in ownership. It marks the beginning of a new phase of growth and creates real added value for European laboratories through innovation, quality, and customer focus.
Related Products
do you have any questions about this article?
We will be happy to help you.
